Granules India Limited has informed the Exchange regarding a press release dated October 18, 2024, titled "Granules India Limited Announces ANDA Approval for Bupropion Hydrochloride Extended-Release Tablets.".
Press Release Oct 18 2024
Filed with NSE · · 3 pages · English
Watch Granules India's latest callGranules India (NSE:GRANULES) Q2 2027 Earnings Call · Replay · Nov 2Read the transcript of Granules India (NSE:GRANULES) Q2 2027 Earnings Call6ix is checking which company filed this.
Earlier from Granules India
- Press Release Sep 24 2024
- Press Release Sep 07 2024
- Press Release Aug 20 2024
- Press Release Aug 09 2024
- Press Release Jul 30 2024
Later from Granules India
- Press Release Nov 06 2024
- Press Release Nov 08 2024
- Press Release Nov 14 2024
- Press Release Nov 27 2024
- Granules India Confirms USFDA Classification Does Not Impact Ongoing Operations, Assures Commitment to Compliance and Growth
Follow Granules India into a list and get an email when it puts out news.
Follow Granules India